Latest Headlines

  1. Europa Biosite Introduces Rapid RNA Production Technologies 3/19/2026

    Europa Biosite has announced a new strategic distribution partnership with Quantoom Biosciences, a leading manufacturer of innovative mRNA technologies for global healthcare advancement supporting next generation vaccines and therapeutics.

  2. Agilent Showcases Advances In Precision Oncology And Digital Pathology At USCAP 2026 3/19/2026

    Agilent Technologies Inc. today announced it will feature its latest advances in precision oncology and digital pathology workflows at the 2026 United States and Canadian Academy of Pathology (USCAP) Annual Meeting, taking place March 21-26 in San Antonio, Texas.

  3. Ibex Expands U.S. Footprint With HNL Lab Medicine Partnership To Deploy Clinical-Grade AI To Support Cancer Diagnostics 3/19/2026

    Ibex Medical Analytics (Ibex), a leader in clinical-grade AI-powered pathology, today announced a strategic collaboration with HNL Lab Medicine, a leading multi-regional medical laboratory in the United States.

  4. Biomerica Receives First Commercial Order For Its H. pylori test (Hp Detect™) From One Of The Largest Clinical Laboratory Chains In Europe 3/18/2026

    Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical diagnostic and therapeutic products, today announced it has received its first commercial order for Hp Detect™, its Helicobacter pylori (H. pylori) diagnostic stool antigen test, from one of the largest clinical laboratory chains operating across Europe.

  5. Cenevo's Labguru Drives Digital Lab Transformation For Pace® Life Sciences 3/18/2026

    Cenevo's Labguru platform is delivering a comprehensive solution to centralize documentation processes at Pace® Life Sciences, a U.S.-based contract development and manufacturing organization (CDMO) and full-service good manufacturing practice (GMP) analytical laboratory service provider.

  6. Helio Genomics To Make HelioLiver™ Cancer Test Accessible To Quest Diagnostics' Providers 3/18/2026

    Helio Genomics, an AI-powered TechBio company focused on early cancer detection, today announced an agreement with Quest Diagnostics, a leading provider of diagnostic information services, to make HelioLiver™, Helio Genomics' innovative blood-based early detection test for Hepatocellular Carcinoma (HCC), widely available to physicians and patients through Quest's extensive U.S. network.

  7. Roche Expands Mass Spectrometry Menu To Include Steroid Assays Receiving CLIA 'Moderate Complexity' Designation 3/18/2026

    Roche announced today that the U.S. Food and Drug Administration (FDA) has categorized its Ionify steroid assays for mass spectrometry as “moderate complexity” under the Clinical Laboratory Improvement Amendments of 1988 (CLIA).

  8. Illumina And Labcorp Expand Collaboration To Broaden Access To Precision Oncology Testing 3/18/2026

    Illumina, Inc. (NASDAQ: ILMN) and Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded collaboration to advance precision oncology through innovative applications of next-generation sequencing (NGS) solutions across the healthcare ecosystem.

  9. Myriad Genetics Receives FDA Approval Of The MyChoice CDx Test As The Companion Diagnostic For Zejula (niraparib) For Patients With Ovarian Cancer 3/17/2026

    Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that the U.S. Food and Drug Administration (FDA) has approved the MyChoice® CDx Test as the Companion Diagnostic (CDx) for Zejula® (niraparib), a PARP inhibitor from GSK, for patients with advanced ovarian cancer.

  10. Aiforia Announces The Next Generation Of Its CE-IVD Marked Prostate Cancer Biopsy AI Solution 3/17/2026

    Aiforia Technologies Plc today announced the launch of the next generation of its clinical AI solution for prostate cancer diagnostics.